Home Workshops Directory Core Facilities CCTRHIB Resources Publications Participating Institutions NIAID Biodefense Biodefense RCEs Useful Links Contact Information
Home
Workshops
Directory
Core Facilities
CCTRHIB Resources
Publications
Participating Institutions
NIAID Biodefense
Biodefense RCEs
Useful Links
Contact Information
Topical Publications April 2005 Vol 4 No 4 The Evolving Field of Biodefense: Therapeutic Developments and Diagnostics James C. Burnett, Erik A. Henchal, Alan L. Schmaljohn & Sina Bavari2 NEWS RELEASES from NIAID Research advances in NIAID's biodefense program are highlighted in news releases issued periodically by NIAID. Reporters who need further information or want to interview NIAID staff should call the Office of Communications and Public Liaison at (301) 402-1663. 2003-2004 Releases | See earlier releases February 1, 2005 New Way To Block Pox Shows Promise In Lab Study November 1, 2004 NIAID Launches Program to Improve Medical Tools Against Emerging Infectious Diseases October 12, 2004 New Study on Smallpox in Monkeys Reveals Tactics of a Killer October 7, 2004 HHS Awards $232 Million in Biodefense Contracts for Vaccine Development July 4, 2004 3-D Structure of Anthrax Toxin Complex Solved May 19, 2004 NIAID Forms Network to Tackle Potentially Fatal Reaction to Smallpox Vaccine March 24, 2004 Mouse Model Mimics Real-World Plague Infection March 10, 2004 Effectiveness of Safer Smallpox Vaccine Demonstrated Against Monkeypox November 18, 2003 NIAID Ebola Vaccine Enters Human Trial September 30, 2003 NIAID Funds Construction of Biosafety Laboratories September 29, 2003 NIAID Reports 'Tremendous Progress' in Biodefense Research September 17, 2003 $85 Million Awarded for Research on Human Immunity and Biodefense September 4, 2003 HHS Announces New Regional Centers for Biodefense Research September 2, 2003 Mouse Study Gives New View of Anthrax Toxin August 6, 2003 Fast-Acting Ebola Vaccine Protects Monkeys April 30, 2003 Anthrax Genome Decoded February 25, 2003 HHS Announces Contracts To Develop Safer Smallpox Vaccines January 8, 2003 Powerful Technologies Probe Innate Immunity Earlier Releases (2002 and before) October 17, 2002 Dr. Marshall Bloom Named Associate Director of Rocky Mt. Laboratories October 15, 2002 USAMRIID-NIAID Announce Research Partnership at Fort Detrick October 3, 2002 HHS Announces Contracts for Developing a New Anthrax Vaccine June 11, 2002 NIAID Expands Vaccine Testing Network May 9, 2002 Researchers Unravel Anthrax Genome April 25, 2002 Single Gene Leap Led to Flea-Borne Transmission of Plague Bacterium March 28, 2002 NIAID Study Results Support Diluting Smallpox Vaccine Stockpile to Stretch Supply March 14, 2002 NIAID Unveils Counter-Bioterrorism Research Agenda December 6, 2001 HHS Accelerates Bioterrorism Research October 23, 2001 NIAID-supported Anthrax studies appearing in the journal Nature November 29, 2000 Novel Vaccine Protects Monkeys from Ebola Infection
Topical Publications
April 2005 Vol 4 No 4
The Evolving Field of Biodefense: Therapeutic Developments and Diagnostics
James C. Burnett, Erik A. Henchal, Alan L. Schmaljohn & Sina Bavari2
NEWS RELEASES from NIAID
Research advances in NIAID's biodefense program are highlighted in news releases issued periodically by NIAID. Reporters who need further information or want to interview NIAID staff should call the Office of Communications and Public Liaison at (301) 402-1663. 2003-2004 Releases | See earlier releases February 1, 2005 New Way To Block Pox Shows Promise In Lab Study November 1, 2004 NIAID Launches Program to Improve Medical Tools Against Emerging Infectious Diseases October 12, 2004 New Study on Smallpox in Monkeys Reveals Tactics of a Killer October 7, 2004 HHS Awards $232 Million in Biodefense Contracts for Vaccine Development July 4, 2004 3-D Structure of Anthrax Toxin Complex Solved May 19, 2004 NIAID Forms Network to Tackle Potentially Fatal Reaction to Smallpox Vaccine March 24, 2004 Mouse Model Mimics Real-World Plague Infection March 10, 2004 Effectiveness of Safer Smallpox Vaccine Demonstrated Against Monkeypox November 18, 2003 NIAID Ebola Vaccine Enters Human Trial September 30, 2003 NIAID Funds Construction of Biosafety Laboratories September 29, 2003 NIAID Reports 'Tremendous Progress' in Biodefense Research September 17, 2003 $85 Million Awarded for Research on Human Immunity and Biodefense September 4, 2003 HHS Announces New Regional Centers for Biodefense Research September 2, 2003 Mouse Study Gives New View of Anthrax Toxin August 6, 2003 Fast-Acting Ebola Vaccine Protects Monkeys April 30, 2003 Anthrax Genome Decoded February 25, 2003 HHS Announces Contracts To Develop Safer Smallpox Vaccines January 8, 2003 Powerful Technologies Probe Innate Immunity Earlier Releases (2002 and before) October 17, 2002 Dr. Marshall Bloom Named Associate Director of Rocky Mt. Laboratories October 15, 2002 USAMRIID-NIAID Announce Research Partnership at Fort Detrick October 3, 2002 HHS Announces Contracts for Developing a New Anthrax Vaccine June 11, 2002 NIAID Expands Vaccine Testing Network May 9, 2002 Researchers Unravel Anthrax Genome April 25, 2002 Single Gene Leap Led to Flea-Borne Transmission of Plague Bacterium March 28, 2002 NIAID Study Results Support Diluting Smallpox Vaccine Stockpile to Stretch Supply March 14, 2002 NIAID Unveils Counter-Bioterrorism Research Agenda December 6, 2001 HHS Accelerates Bioterrorism Research October 23, 2001 NIAID-supported Anthrax studies appearing in the journal Nature November 29, 2000 Novel Vaccine Protects Monkeys from Ebola Infection
Research advances in NIAID's biodefense program are highlighted in news releases issued periodically by NIAID.
Reporters who need further information or want to interview NIAID staff should call the Office of
Communications and Public Liaison at (301) 402-1663.
2003-2004 Releases | See earlier releases
February 1, 2005 New Way To Block Pox Shows Promise In Lab Study November 1, 2004 NIAID Launches Program to Improve Medical Tools Against Emerging Infectious Diseases October 12, 2004 New Study on Smallpox in Monkeys Reveals Tactics of a Killer October 7, 2004 HHS Awards $232 Million in Biodefense Contracts for Vaccine Development July 4, 2004 3-D Structure of Anthrax Toxin Complex Solved May 19, 2004 NIAID Forms Network to Tackle Potentially Fatal Reaction to Smallpox Vaccine March 24, 2004 Mouse Model Mimics Real-World Plague Infection March 10, 2004 Effectiveness of Safer Smallpox Vaccine Demonstrated Against Monkeypox November 18, 2003 NIAID Ebola Vaccine Enters Human Trial September 30, 2003 NIAID Funds Construction of Biosafety Laboratories September 29, 2003 NIAID Reports 'Tremendous Progress' in Biodefense Research September 17, 2003 $85 Million Awarded for Research on Human Immunity and Biodefense September 4, 2003 HHS Announces New Regional Centers for Biodefense Research September 2, 2003 Mouse Study Gives New View of Anthrax Toxin August 6, 2003 Fast-Acting Ebola Vaccine Protects Monkeys April 30, 2003 Anthrax Genome Decoded February 25, 2003 HHS Announces Contracts To Develop Safer Smallpox Vaccines January 8, 2003 Powerful Technologies Probe Innate Immunity
Earlier Releases (2002 and before)
October 17, 2002 Dr. Marshall Bloom Named Associate Director of Rocky Mt. Laboratories October 15, 2002 USAMRIID-NIAID Announce Research Partnership at Fort Detrick October 3, 2002 HHS Announces Contracts for Developing a New Anthrax Vaccine June 11, 2002 NIAID Expands Vaccine Testing Network May 9, 2002 Researchers Unravel Anthrax Genome April 25, 2002 Single Gene Leap Led to Flea-Borne Transmission of Plague Bacterium March 28, 2002 NIAID Study Results Support Diluting Smallpox Vaccine Stockpile to Stretch Supply March 14, 2002 NIAID Unveils Counter-Bioterrorism Research Agenda December 6, 2001 HHS Accelerates Bioterrorism Research October 23, 2001 NIAID-supported Anthrax studies appearing in the journal Nature November 29, 2000 Novel Vaccine Protects Monkeys from Ebola Infection
Web Design by Brookline Design
webmaster@cctrhib.org
